Scienture Holdings Inc
trxadehealth.comWhat Do They Do?
Develops and sells specialty medicines for cardiovascular and central nervous system conditions to pharmaceutical wholesalers, specialty pharmacies and distributors.
10-K for FY2025, filed Mar 30, 2026
How Do They Make Money?
The company earns revenue from pharmaceutical product sales through wholesale distributors, with each sale counted generally upon delivery to the distributor.
10-K for FY2025, filed Mar 30, 2026The Company’s sole source of revenue is product revenue from the sale of pharmaceutical products through wholesale distribution channels.…View ↗
$431.6K
-
10-K for FY2025, filed Mar 30, 2026
$431.6K ↗
Who Are Their Customers?
The company expects most sales to go to pharmaceutical wholesalers, specialty pharmacies and distributors, which resell products to pharmacies, hospitals, long-term care institutions and other customers. Its U.S. commercial effort uses a contract sales organization to reach health care providers.
10-K for FY2025, filed Mar 30, 2026
Do Revenues Turn Into Profits?
No. It lost $41.5M in FY2025.
10-K for FY2025, filed Mar 30, 2026
How Are They Changing?
-
Aug 20, 2026
Launched REZENOPY as its second commercial product
The company began fulfilling initial purchase orders, adding a second product to its commercial portfolio.
Sources
8-K, filed Aug 20, 2026
Commenced Commercial Launch of REZENOPY™, Establishing the Company’s Second Commercial Product and Expanding Its Revenue-Generating…View ↗
-
May 29, 2026
CFO resigned and the company appointed an interim CFO
Eric Sherb resigned as CFO; Dr. Narasimhan Mani was appointed interim CFO.
Sources
8-K, filed May 29, 2026
On May 26, 2026, Eric Sherb, the Chief Financial Officer (“CFO”) of Scienture Holdings, Inc. (the “Company”), formally resigned his…View ↗
Shrinking. Revenue fell 96% in 4 years, from $9.9M in FY2021 to $431.6K in FY2025, about 54% a year.
From healthcare services to specialty medicines
The older report described a web-based pharmaceutical trading platform, distribution logistics, a specialty pharmacy and telehealth; the latest centers the business on developing and commercializing medicines for cardiovascular and central nervous system conditions.
10-K for FY2022, filed Mar 27, 2023 10-K for FY2025, filed Mar 30, 2026We own 100% of Trxade Inc. (a Florida corporation). This subsidiary is included in our attached consolidated financial statements and is…View ↗
We own 100% of Integra Pharma Solutions, LLC (formerly Pinnacle Tek, Inc., a Florida corporation) founded by Mr. Suren Ajjarapu, our CEO…View ↗
We own 100% of Community Specialty Pharmacy, LLC, an independent retail specialty pharmacy with a focus on specialty medications.View ↗
We own 100% of Bonum Health, LLC, a Delaware limited liability company which owns our “Bonum Health Hub” assets and operations as discussed…View ↗
Scienture LLC is a specialty pharmaceutical company focused on the commercialization and development of products for the treatment of…View ↗
Loading...
